RecruitingOBSERVATIONAL

The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

Researchers are conducting a study called "The Monument Test" to learn more about how Alzheimer's disease affects memory and the ability to name things. They want to see if there's a clear difference in how people with Alzheimer's and healthy older adults identify and name famous landmarks. By comparing their performance on a special task, scientists hope to better understand the challenges faced by those with Alzheimer's. This study involves people aged 50 to 95. Taking part would mean doing an identification and naming activity. This research could help develop better ways to assess and understand Alzheimer's disease.

At a glance

Status

Recruiting

Sponsor

University Hospital, Grenoble

Enrolment target

220

Start

23 Feb 2026

Estimated completion

01 Feb 2032

Alzheimer s Disease

What is this study about?

This study, known as "The Monument Test," aims to understand more about memory and naming difficulties faced by people with Alzheimer's disease. Researchers believe that by looking at how well people recall and name famous landmarks, they might find new ways to identify and assess changes in memory that come with Alzheimer's.

The main idea is to compare two groups of people: older adults who are generally healthy, and older adults who have been diagnosed with Alzheimer's disease. Both groups will be asked to do a task that involves identifying and naming well-known monuments. The scientists expect that there will be a noticeable difference in how these two groups perform.

Ultimately, the information gathered from this study could be very helpful. It might lead to better tools for doctors to understand and diagnose Alzheimer's disease, and potentially improve support for those living with the condition. It's an important step in learning more about how our brains work and what happens when they are affected by diseases like Alzheimer's.

Key takeaways

The study helps understand how Alzheimer's affects recognizing and naming things.
It compares people with Alzheimer's to healthy older adults.
Participation involves a single task of identifying famous places.
It could lead to better ways to assess Alzheimer's disease.
It's open to men and women aged 50 to 95.

Who may be eligible?

To join this study, you must be 50 years old or older. The study is looking for two main groups of people: those who have been diagnosed with Alzheimer's disease and healthy older adults.

If you have Alzheimer's disease, your doctor would have confirmed your diagnosis, and you would need to meet certain scores on a routine memory test. If you are a healthy older adult, you would also need to be 50 or older and have a good score on the same memory test, without experiencing memory problems.

There are also some reasons why you might not be able to join. For example, if you have other serious brain conditions, are taking certain medications for mental health, have significant hearing or vision problems, or have trouble understanding French (as the original study was conducted in French, this would be adapted for a UK context) you likely wouldn't be able to take part. It's also important that you have some general knowledge about famous places, as this is what the test focuses on.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 50 years old or older?
Do you have a diagnosis of Alzheimer's disease, or are you a healthy older adult with no significant memory complaints?
Do you have good hearing and eyesight (with glasses/hearing aids if needed)?
Are you able to speak and understand English well (as this study would be adapted for UK patients)?
Do you have some general knowledge about famous landmarks and culture?

Answer every question to see your result.

What does participation involve?

The study involves a single visit where you will take part in an identification and naming task. This means you will be shown pictures of famous monuments and asked to identify and name them. The researchers will observe and record your responses. No medication will be given as part of this study, and there won't be any long-term follow-up visits. The total time commitment for participating in this study will be relatively short, likely no more than an hour or two for the assessment itself.

Potential risks and benefits

Taking part in this study could help advance our understanding of Alzheimer's disease, potentially leading to better diagnostic tools. While there are no direct medical benefits to you personally, your contribution will be valuable to research. The main risk is the time commitment, and some people might find the identification and naming task a little challenging, but it's not designed to be overly stressful. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

CHU Grenoble Alpes
Verified postcode
Grenoble, France· Recruiting

Common questions

What is the main goal of this study?

The study aims to see if there's a clear difference in how people with Alzheimer's and healthy older adults identify and name famous monuments, helping researchers understand memory changes.

What will I have to do if I take part?

You will be asked to complete a task where you identify and name famous monuments. It's a single session and does not involve medication.

Who can take part in this study?

People aged 50 and above can take part. This includes those with a diagnosed form of Alzheimer's disease and healthy older adults.

How long will participation take?

Participation will involve a single session, likely lasting no more than an hour or two for the naming task.

Are there any side effects or risks?

There are no medical side effects. The main 'risk' is the time commitment. You can stop participating at any point.

How to find out more

Sabrina Iannuzzi, Neuropsychologist

siannuzzi@chu-grenoble.fr +334.76.76.57.90 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.